Abrin
Abrin
Main page
1977531

Abrin

logo
Community Hub0 subscribers
Read side by side
Abrin
View on Wikipedia
from Wikipedia

Abrin-a
Abrin-a structure (PDB: 1ABR​). The A chain is shown in blue and the B chain in olive. A single peptide is cleaved into the two chains.
Identifiers
OrganismAbrus precatorius
Symbol?
CAS number1393-62-0
UniProtP11140
Search for
StructuresSwiss-model
DomainsInterPro
Abrin
Identifiers
ChemSpider
  • none
KEGG
RTECS number
  • AA5250000
UNII
UN number 3462
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Abrin is an extremely toxic toxalbumin found in the seeds of the rosary pea (or jequirity pea), Abrus precatorius. It has a median lethal dose of 0.7 micrograms per kilogram of body mass when given to mice intravenously (approximately 3.86 times more toxic than ricin, being 2.7 micrograms per kilogram).[1] The median toxic dose for humans ranges from 10 to 1000 micrograms per kilogram when ingested and is 3.3 micrograms per kilogram when inhaled.[2]

Abrin is a ribosome inhibiting protein like ricin, a toxin which can be found in the seeds of the castor oil plant,[3] and pulchellin, a toxin which can be found in the seeds of Abrus pulchellus.[4] Abrin is classed as a "select agent" under U.S. law.

Occurrence

[edit]

Abrin is naturally produced exclusively by the rosary pea and constitutes approximately 0.08% of the plant's brightly colored seeds. The release of the toxin is inhibited by the seed coat; thus, if the seed coat is damaged or destroyed (for instance, by chewing), the toxin may be released.

The rosary pea is the source plant of abrin

Physical properties

[edit]

Abrin is a water-soluble[5] lectin. Abrin in powdered form is yellowish-white. It is a stable substance.[5][6] It can withstand 30 minutes of heating at 60 °C (140 °F), but loses most of its toxicity after 30 minutes at 80 °C (176 °F).[7] Though it is combustible, it does not polymerize easily and is not particularly volatile.[6]

Biochemistry

[edit]

Chemically, abrin is a mixture of four isotoxins, these being abrin-a (P11140), -b (Q06077), -c (P28590), and -d (Q06076). Occasionally, the homologous low-toxicity[8] hemagglutinin of Abrus precatorius (Q9M6E9; AAG) is also included as the fifth protein under the collective name 'abrin'.

A comparison of the similar structures of abrin-a (red) and ricin (blue)

Abrin-a is the most potent of the four isotoxins, encoded for by an intron-free gene, and consists of two subunits or chains, A and B. The primary product of protein biosynthesis, preproabrin, consists of a signal peptide sequence, the amino acid sequences for subunits A and B, and a linker. A molecule of abrin-a has a total of 528 amino acids and is about 65 kDa in mass. Abrin-a is formed after the cleavage of a signal peptide sequence and post-translational modifications such as glycosylation and disulfide bridge formation in the endoplasmic reticulum (ER). The other three abrins, as well as the agglutinin, have a similar structure.

In terms of structure, abrin-a is related to the lectin, ricin, produced in the seeds of Ricinus communis.

Use

[edit]

Abrin is not known to have been weaponised.[5] However, due to its high toxicity and the possibility of being processed into an aerosol, the use of abrin as a biological weapon is possible in principle.[9] Despite this, the rosary pea yields only small quantities of abrin, which reduces the risk.

The rosary pea is common to tropical regions, and is occasionally employed as an herbal remedy for certain conditions.[10] While the outer shell of the seed protects its contents from the stomachs of most mammals, the seed coats are occasionally punctured to make beaded jewelry. This can lead to poisoning if a seed is swallowed, or if such jewelry is worn against damaged skin.[6]

Abrin has been shown to act as an immunoadjuvant in the treatment of cancer in mice.[11]

Toxicology

[edit]

Symptoms of abrin poisoning include diarrhea, vomiting, colic, tachycardia, and tremors. Death usually occurs after a few days due to kidney failure, heart failure, and/or respiratory paralysis.

Toxicity

[edit]

Although there is no consensus on the level of lethal dose in humans after oral intake, it is assumed that the intake of 0.1 to 1 microgram per kilogram of body weight, or the consumption of a single seed of the rosary pea, may be fatal, but this information is insufficiently documented.[9] According to other estimates, the LD50 value of abrin is between 10 and 1000 μg/kg and is comparable to that of ricin.[12] The severity of the effects of abrin poisoning vary on the means of exposure to the substance (whether inhaled, ingested, or injected).[5][6] Exposure to abrin on the skin can cause an allergic reaction, indicated by blisters, redness, irritation, and pain,[6] however, there is no evidence of toxicity after skin contact.

Abrin is significantly more toxic following intravenous administration. The LD50 values obtained vary between 0.03 and 0.06 μg/kg in rabbits and between 1.25 and 1.3 μg/kg in dogs, depending on the species.[13] In clinical studies involving cancer patients, up to 0.3 μg/kg of intravenous abrin immunotoxin was tolerated without the development of serious symptoms of toxicity.

The toxicity of abrin is increased if it is inhaled. In rats, the LD50 for this route of administration is 3.3 μg/kg.[14]

Toxicodynamics

[edit]

Abrin resembles ricin, in that it also is a type 2 ribosome-inactivating protein (RIP-II) with a similar mode of action, but the effect of abrin is more potent than that of ricin.[15] The toxic effect of abrin is due to an intracellular, multi-step process. Abrin binds to and penetrates the cells of the body, inhibiting cell protein synthesis after being transported to the endoplasmic reticulum (ER). By attaching its non-specifically binding B chain, which acts as a haptomer, to the carbohydrate chain of a glycoprotein on the cell surface, the abrin molecule anchors itself to the cell and is subsequently engulfed. However, both specific and nonspecific binding result in the uptake of abrin via endocytosis, as well as the activation of the A chain, caused by the cleavage of the B chain. The activated A chain of abrin, the effectomer, then enters the inner parts of the cell, where it cleaves an adenine (A4324) nucleobase from the 28S rRNA of the large ribosomal subunit of a ribosome on or near the ER, inhibiting the regular process of cellular protein synthesis. Without these proteins, cells cannot survive. This is harmful to the human body and can be fatal in small exposures. Additionally, abrin also may bind to cells specifically bearing the mannose receptor on their surface; since this receptor is found in a particularly high density on cells of the reticulohistiocytic system, that system in particular is affected by the toxicity of abrin.[9]

Toxicokinetics

[edit]

Information dealing with the toxicokinetics of abrin is limited and debated. Due to its biochemical properties and its similarity to ricin, it is believed that abrin is at least partially degraded in the gastrointestinal tract.[16] The size of the molecule also restricts absorption through the gastrointestinal tract. Nevertheless, the numerous deaths caused from consuming rosary pea seeds confirm that enough of the toxin can be absorbed into the systemic circulation via the gastrointestinal tract to cause death.[9]

Murine studies show that there is an accumulation of abrin after injection, in the liver, kidneys, spleen, blood cells, lungs, and heart. The molecule is excreted via the kidneys after it undergoes proteolytic cleavage.[17]

Signs and symptoms of abrin exposure

[edit]

The major symptoms of abrin poisoning depend on the route of exposure and the dose received, though many organs may be affected in severe cases. In general, symptoms can appear anywhere between several hours to several days after exposure. Initial symptoms of abrin poisoning by inhalation may occur within 8 hours of exposure but a more typical time course is 18–24 hours; they can prove fatal within 36–72 hours. Following ingestion of abrin, initial symptoms usually occur rapidly, but can take up to five days to appear.[6]

The later signs and symptoms of exposure are caused by abrin's cytotoxic effects, killing cells in the kidney, liver, adrenal glands, and central nervous system.[6]

Inhalation

[edit]

Within a few hours of inhaling abrin, common symptoms include fever, cough, airway irritation, chest tightness, pulmonary edema (excess fluid accumulated in the lungs), and nausea. This makes breathing difficult (called dyspnea), and the skin might turn blue or black in a condition called cyanosis, which is a symptom of hypoxia. Excess fluid in the lungs can be diagnosed by x-ray or by listening to the chest with a stethoscope. As the effects of abrin progress, a person can become diaphoretic (sweating heavily) and fluid can build up further. Their blood pressure may drop dramatically, keeping oxygen from reaching the brain and other vital organs in a condition called shock, and respiratory failure may occur, which can be fatal within 36 to 72 hours. If an exposure to abrin by inhalation is not fatal, the airway can become sensitized or irritated.[6]

Ingestion

[edit]

Swallowing any amount of abrin can lead to a slow-burn process of severe symptoms. Early symptoms include nausea, vomiting, pain in the mouth, throat, and esophagus, diarrhea, dysphagia (trouble swallowing), and abdominal cramps and pain. As the symptoms progress, bleeding and inflammation begins in the gastrointestinal tract. The affected person can vomit up blood (hematemesis), have blood in their feces, which creates a black, tarry stool called melena, and more internal bleeding. Loss of blood volume and water from nausea, vomiting, diarrhea, and bleeding causes blood pressure to drop and organ damage to begin, which can be seen as the person begins to have somnolence/drowsiness, hematuria (blood in the urine), stupor, convulsions, polydipsia (excessive thirst), and oliguria (low urine production). This ultimately results in multi-system organ failure, hypovolemic shock, vascular collapse, and death.[6]

Absorption

[edit]

Abrin can be absorbed through broken skin or absorbed through the skin if dissolved in certain solvents. It can also be injected in small pellets and absorbed through contact with the eyes. Abrin in the powder or mist form can cause redness and pain in the eyes (i.e. conjunctivitis) in small doses. Small doses absorbed through the eyes can also cause tearing (lacrimation). Higher doses can cause tissue damage, severe bleeding at the back of the eye (retinal hemorrhage), and vision impairment or blindness. A large enough dose can be absorbed into the bloodstream and lead to systemic toxicity.[6]

Treatment

[edit]

Because no antidote exists for abrin, the most important factor is avoiding abrin exposure in the first place. If exposure cannot be avoided, the most important factor is then getting the abrin off or out of the body as quickly as possible. Abrin exposure can be prevented when it is present in large quantities by wearing appropriate personal protective equipment. Abrin poisoning is treated with supportive care to minimize the effects of the poisoning. This care varies based on the route of exposure and the time since exposure. For recent ingestion, administration of activated charcoal and gastric lavage are both options. Using an emetic (vomiting agent) is not a useful treatment. In cases of eye exposure, flushing the eye with saline helps to remove abrin. Oxygen therapy, airway management, assisted ventilation, monitoring, IV fluid administration, and electrolyte replacement are also important components of treatment.[6]

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Abrin

View on Grokipedia
from Grokipedia
Abrin is an extremely toxic toxalbumin, a type II ribosome-inactivating protein, extracted from the seeds of the Abrus precatorius plant, known as the rosary pea or jequirity pea, which features distinctive red seeds with a black spot.[1][2] The toxin consists of two polypeptide chains linked by a disulfide bond: the A-chain enzymatically depurinates ribosomal RNA to halt protein synthesis, leading to cell death, while the B-chain facilitates cellular entry by binding to galactose residues on cell surfaces.[3][4] Abrin exhibits potency surpassing that of ricin, with an estimated human lethal dose of 0.1–1 μg/kg body weight via injection or inhalation, and even ingestion of a single chewed seed can prove fatal due to the toxin's resistance to degradation when the seed coat is breached.[5][6] No specific antidote exists, rendering treatment supportive and reliant on early intervention to mitigate gastrointestinal, hepatic, and systemic effects.[4] Native to tropical regions including India, A. precatorius seeds have been employed in traditional medicine and as beads in jewelry, though their toxicity has resulted in accidental and intentional poisonings, with rare survivals documented after aggressive decontamination and care.[7][8] Due to its ease of extraction into aerosolizable forms and high lethality, abrin is classified as a potential biotoxin agent, prompting development of detection methods and awareness in public health contexts.[6][7]

Source and Occurrence

Botanical Origin

Abrin is a toxic lectin protein derived exclusively from the seeds of Abrus precatorius L., a perennial twining vine belonging to the genus Abrus in the Fabaceae family (Leguminosae).[9][7] The species is classified under the order Fabales, subclass Rosidae, and class Magnoliopsida within the division Magnoliophyta of seed plants.[10] This woody vine produces herbaceous branches and pinnate leaves, with seeds serving as the primary repository for abrin isoforms, including abrin-a, abrin-b, abrin-c, and abrin-d.[11][7] The seeds of A. precatorius exhibit distinctive morphology: small, hard legumes approximately 5-6 mm long, typically scarlet red with a polished surface and a prominent black hilum at one end, earning common names like rosary pea, crab's eye, or jequirity pea.[12] Abrin, functioning as a heterodimeric glycoprotein, comprises a notable fraction of the seed's soluble protein content, with reported purification yields of about 0.15% from mature kernels.[13] These lectins are synthesized in the seeds as part of the plant's protein profile, akin to other Fabaceae species where such proteins accumulate during seed development.[14] In the evolutionary context of legumes, abrin exemplifies type II ribosome-inactivating proteins (RIPs) that likely arose from ancestral carbohydrate-binding domains, enabling roles in seed storage and potential defense through glycan recognition.[15] Empirical isolation studies confirm abrin's concentration is tied to seed maturation, though precise quantitative variation remains documented primarily through biochemical yields rather than developmental gradients.[16][13]

Geographical Distribution

Abrus precatorius originates from tropical and subtropical regions of the Old World, encompassing parts of Africa, tropical Asia (including India and Southeast Asia), and northern and eastern Australia, where it inhabits seasonally dry biomes as a climbing shrub.[17] The species favors disturbed habitats such as scrublands, forest edges, and abandoned fields, often spreading via its climbing habit and seed dispersal by birds and water.[18] Human-mediated introduction, primarily through trade of its brightly colored seeds for beads and ornaments, has facilitated its establishment in New World tropics, including the Americas, West Indies, and Pacific islands, where it has naturalized extensively.[19] In areas like peninsular Florida, it has become invasive, displacing native vegetation in disturbed sites up to latitudes corresponding to Marion County.[20] Naturalized populations are documented in southeastern Queensland and northeastern New South Wales, Australia, reflecting both intentional cultivation and unintended spread.[21] Empirical data on abrin concentration indicate variability across populations, with seeds from wild specimens in native ranges like India yielding detectable levels of the toxin, though quantitative comparisons between wild and cultivated variants lack comprehensive field validation in peer-reviewed studies.[7] Environmental stressors such as salinity and temperature influence seed germination rates, potentially affecting overall plant vigor and toxin production indirectly, as observed in germination trials under varying conditions.[22]

Physicochemical Properties

Molecular Composition

Abrin is a heterodimeric glycoprotein toxin belonging to the class of type II ribosome-inactivating proteins (RIPs). It consists of two non-identical polypeptide chains: the enzymatically active A-chain, which exhibits RNA N-glycosidase activity, and the B-chain, a lectin capable of binding terminal galactose residues. These chains are linked by a single interchain disulfide bond, with the overall molecular mass of the holotoxin ranging from 60 to 65 kDa.[23][24][25] The A-chain has a molecular weight of approximately 30 kDa, while the B-chain weighs about 33-35 kDa, enabling the B-chain to mediate cell surface binding through its two galactose-specific binding sites, which facilitate receptor-mediated endocytosis and subsequent delivery of the A-chain to the ribosomal machinery.[26][27] Abrin exists in four primary isoforms—abrin-a, -b, -c, and -d—isolated from the seeds of Abrus precatorius, which differ mainly in their N-glycosylation patterns and minor sequence variations, though abrin-a is the most abundant and potent variant with a well-characterized crystal structure. These isoforms share a conserved core fold similar to ricin, with the A-chain adopting an α/β fold typical of RIPs and the B-chain featuring a β-trefoil architecture for carbohydrate recognition.[28][7][25] Purification studies indicate that abrin constitutes roughly 1-5% of the total seed protein content by weight, reflecting its role as a defensive lectin in the plant.[29]

Stability and Physical Traits

Abrin demonstrates notable thermal resilience, retaining toxicity after exposure to temperatures as high as 74°C, with complete inactivation requiring sustained heating at 74°C or above.[30] A 2017 study by USDA Agricultural Research Service researchers found abrin remained stable in cell-free translation assays following heat treatments at 63°C, 74°C, 80°C, 85°C, and 99°C, though partial denaturation occurs around 80°C after 30 minutes, leading to substantial loss of activity.[31] [2] This heat tolerance persists in various matrices, including dairy products, where lower temperatures fail to eliminate bioactivity.[32] The toxin exhibits broad pH tolerance, with no significant reduction in toxicity across tested ranges, performing optimally at neutral pH while resisting acidic or basic conditions that degrade many proteins.[30] Such environmental durability contributes to abrin's persistence in settings prone to pH fluctuations, like contaminated soils or processed foods. In physical form, purified abrin manifests as a yellowish-white powder, soluble in water, which enhances its potential for aerosolization or dissemination in aqueous environments.[33] Its stability endures for days to weeks—or up to months—in powdered or solubilized states, depending on humidity, temperature, and contaminants, posing sustained contamination risks distinct from more labile biological agents.[34] This resilience facilitates unintended persistence in food chains or deliberate dispersal, as evidenced by minimal degradation under standard environmental stressors.[33]

Biochemical Mechanism

Cellular Action

Abrin, a type II ribosome-inactivating protein, exerts its cellular toxicity through the coordinated action of its A and B chains. The B chain, a lectin, binds specifically to terminal galactose residues on cell surface glycoproteins and glycolipids, enabling receptor-mediated endocytosis of the holotoxin.[30][35] This binding initiates clathrin-dependent uptake into endosomes, followed by retrograde transport to the Golgi and endoplasmic reticulum, where the disulfide-linked chains separate, allowing the A chain to translocate to the cytosol.[36] Biochemical assays confirm that isolated B chain retains galactose-binding affinity comparable to the intact toxin, with dissociation constants in the nanomolar range.[37] In the cytosol, the A chain functions as an RNA N-glycosidase, catalyzing the depurination of a conserved adenine residue (A4324) in the sarcin/ricin loop of the 28S rRNA within the 60S ribosomal subunit.[38] This modification disrupts the loop's structure, preventing elongation factors EF-1 and EF-2 from binding and halting peptide chain elongation during translation, thereby irreversibly inhibiting protein synthesis.[39] Cell-free and cellular assays demonstrate the A chain's catalytic potency, with one molecule capable of inactivating thousands of ribosomes due to its enzymatic turnover.[40] Empirical inhibition data from luciferase reporter assays show the A chain achieving 50% inhibition of protein synthesis (IC50) at approximately 10 ng/mL in eukaryotic cell extracts.[41] Whole-toxin cytotoxicity assays in human cell lines, such as HeLa cells, yield IC50 values as low as 0.14 ng/mL, reflecting efficient internalization and ribosomal targeting.[42] This mechanism exploits the universal architecture of eukaryotic ribosomes, lacking endogenous repair pathways for the depurinated rRNA, resulting in progressive cellular depletion of proteins essential for survival.[43]

Comparison with Related Toxins

Abrin and ricin belong to the family of type II ribosome-inactivating proteins (RIPs), sharing a heterodimeric structure consisting of an A-chain with N-glycosidase activity that depurinates the sarcin/ricin loop of 28S rRNA, thereby halting protein synthesis, and a B-chain lectin that facilitates binding to cell surface galactosyl residues and subsequent endocytosis.[44][35] The A-chains exhibit approximately 40% sequence homology, while the B-chains share about 60%, contributing to analogous cellular intoxication mechanisms but with quantitative differences in efficiency.[45] Abrin demonstrates substantially higher toxicity than ricin across species and routes, with mouse intravenous LD50 values reported as low as 0.04 μg/kg for abrin compared to higher thresholds for ricin, rendering abrin up to 75 times more potent in some models.[3][35] Estimated human oral median lethal doses further underscore this disparity, at 0.01–0.04 μg/kg for abrin versus 0.1–1 μg/kg for ricin.[45] This enhanced potency arises from abrin's B-chain exhibiting greater affinity for target galactosyl groups and more effective intracellular translocation of the A-chain, leading to amplified ribosomal inactivation per molecule.[46] Differences in N-glycosylation patterns between abrin and ricin influence their immunogenicity and host immune recognition, with abrin's profile showing substantive glycosylation on its A-chain akin yet not identical to ricin's, potentially affecting antibody cross-reactivity and vaccine development challenges.[47] Recent advancements, such as 2024 mass spectrometric workflows employing affinity enrichment and depurination assays, enable precise differentiation of enzymatically active abrin from ricin in complex matrices, addressing prior detection ambiguities due to structural similarities.[48] Despite comparable bioterrorism potential as highly toxic, plant-derived select agents with low production barriers, abrin receives less public and media scrutiny than ricin, though both warrant equivalent biosecurity measures given their accessibility and lethality.[42][49]

Historical Context

Early Discovery and Toxicology Studies

The seeds of Abrus precatorius have been known for their toxicity since ancient times in India, where extracts were empirically used as poisons for livestock and vermin, with documented fatal effects observed in early veterinary and medicinal texts.[50] Accidental human ingestions, often from seeds incorporated into jewelry or necklaces, were reported in 19th-century medical literature, manifesting in severe gastrointestinal hemorrhage, dehydration, and multi-organ failure, with lethality occurring after consumption of as few as 1-3 intact seeds in adults.[51] Scientific characterization advanced in the late 19th century; in 1884, Warden and Waddell proposed that the toxic principle, termed abrin, was proteinaceous based on precipitation and denaturation tests from seed extracts.[52] This was corroborated in 1887 by Martin, who classified abrin as an albumose—a proto-protein—and demonstrated its agglutinating effects on erythrocytes, establishing it as the first identified toxic protein akin to the contemporaneous discovery of ricin.[27] Early empirical toxicology focused on animal models, revealing intravenous lethality in rabbits at doses of 0.03-0.06 μg/kg by the early 20th century, though precise mechanisms remained unelucidated until later protein synthesis inhibition studies.[53] A milestone in understanding abrin's selective action occurred in 1970, when in vitro experiments showed abrin exhibited markedly higher cytotoxicity toward tumor cell lines (e.g., sarcoma and carcinoma cells) compared to normal fibroblasts, with IC50 values 10-100 times lower for malignant cells, attributed to differential membrane binding and uptake.[54] This prompted foundational biochemical assays confirming abrin's ribosome-inactivating properties, paving the way for LD50 quantifications in rodents, such as 1.25 μg/kg subcutaneously in mice and 3.3 μg/kg via inhalation in rats, derived from dose-response curves in controlled exposures.[55] These studies underscored abrin's potency exceeding ricin by factors of 5-10 in certain routes, based on survival rates and histopathological evidence of hepatic and renal necrosis.[56]

Traditional and Cultural Uses

The seeds of Abrus precatorius, the source of abrin, have been employed in various cultural practices, particularly as beads for jewelry, necklaces, and rosaries due to their vibrant red coloration with a black spot, resembling the eye of a bird.[57] These uses persist in regions such as India, Africa, and parts of Asia, where the seeds are also incorporated into percussion instruments, despite awareness of their toxicity when the intact hard shell is compromised by drilling, nicking, or chewing, which exposes the abrin toxin.[57] In traditional systems, the seeds served as units of weight measurement in South Asian commerce, known as "ratti," standardized at approximately 1.75 grains, though this application carried risks if seeds were damaged during handling.[58] In Ayurvedic medicine, A. precatorius seeds, referred to as Gunja, are traditionally processed through detoxification methods like Shodhana (purification via soaking, boiling, or milk treatment) to mitigate toxicity before use in formulations for conditions such as sciatica, alopecia, arthritis pain, and as an aphrodisiac.[59] Claims include anti-inflammatory and hair restorative effects, with roots and seeds applied externally or in minute internal doses for nervous disorders, skin ailments, and erectile dysfunction, though ancient texts emphasize strict purification to avoid abrin-induced harms like gastrointestinal distress or paralysis.[59] Similar folk applications appear in Chinese and African traditions for treating bronchitis, sore throat, jaundice, and abdominal disorders, often using leaves or roots rather than seeds to reduce risk.[58] Documented risks underscore the dangers of cultural uses, with accidental ingestions from beaded jewelry leading to severe abrin poisoning, particularly in children who chew the seeds; for instance, cases report gastrointestinal hemorrhage, organ failure, and fatalities when as few as one to three seeds are breached.[60] An 18-month-old child developed life-threatening symptoms after ingesting a single rosary pea bead, highlighting how intact shells provide partial protection but fail if pierced for crafting.[60] Despite these incidents, cultural persistence continues in artisanal goods, prompting warnings from poison control centers against importing or handling such items without verifying seed integrity.[4]

Toxicity Profile

Lethal Doses and Potency

Abrin demonstrates exceptional lethality, with the intravenous LD50 in mice ranging from 0.4 to 0.7 μg/kg body weight, depending on the isolate and experimental conditions.[61][62] Intraperitoneal LD50 values in mice are similarly low, at approximately 0.91 μg/kg for purified abrin.[63] These figures underscore abrin's potency as a ribosome-inactivating protein, far exceeding that of many known toxins on a per-weight basis. Human lethality estimates derive from animal extrapolations and sparse clinical data, placing the fatal dose at 0.1-1 μg/kg body weight for systemic exposure.[63] [64] Documented fatalities, including intentional ingestions of crushed Abrus precatorius seeds, align with this threshold, as even minute quantities—equivalent to a fraction of a single seed's toxin content—have proven lethal without intervention.[64] No antidote exists, and survival hinges on supportive care, with purity of the abrin extract critically influencing outcomes; impure seed-derived preparations may exhibit variable toxicity due to contaminants or incomplete extraction.[65] Route of administration markedly modulates potency, with parenteral (e.g., intravenous or intramuscular) delivery bypassing digestive barriers and yielding higher bioavailability than oral ingestion, where proteolytic degradation in the gut attenuates lethality by up to several orders of magnitude.[30] Aerosolized or injected forms amplify risk, as evidenced by animal models showing rapid systemic distribution.[34] Empirical data refute assertions of a safe threshold, as traditional handling practices (e.g., using intact seeds for jewelry) fail to eliminate risk from accidental breakage or abrasion, with verified poisonings demonstrating no non-lethal exposure limit.[64][5]
Species/RouteLD50 (μg/kg)Source
Mouse, IV0.4-0.7CDC/NIOSH; peer-reviewed toxicology[61][62]
Mouse, IP0.91Purification study[63]
Human (est.)0.1-1Extrapolation from cases[63][64]

Toxicodynamics

Abrin inhibits protein synthesis within target cells by its A-chain enzymatically depurinating a conserved adenine residue (A4324) in the 28S ribosomal RNA sarcin/ricin loop, thereby preventing the binding of elongation factors EF-1 and EF-2 during translation and inducing apoptosis through accumulation of unfinished polypeptides and ribosomal stress.[66] This ribosomal inactivation primarily affects cells with high protein synthesis rates, such as vascular endothelial cells and epithelial linings, initiating a cascade of cellular damage that manifests as increased capillary permeability, tissue edema, and necrosis.[2] Empirical data from cell culture models demonstrate organ-specific sensitivities, with pulmonary alveolar cells (e.g., A549 line) exhibiting the highest vulnerability (CC₅₀ ≈ 2 ng/mL) due to rapid uptake and oxidative stress, while hepatic cells (e.g., Hep G2) show relative resistance (CC₅₀ ≈ 500 ng/mL) linked to elevated anti-apoptotic Bcl-2 expression and delayed mitochondrial dysfunction.[39] In animal models, such as Swiss albino mice administered intraperitoneal doses near the LD₅₀ (0.91 μg/kg), abrin triggers dose-dependent histopathological changes observable within 24 hours, progressing to severe multi-organ pathology by 72 hours and beyond. Low sublethal doses (0.4 LD₅₀) induce minimal overt tissue disruption but elevate markers of oxidative stress (e.g., increased lipid peroxidation, decreased glutathione in liver), whereas lethal doses (1.0 LD₅₀) cause hepatic congestion with centrilobular necrosis, renal tubular degeneration, and splenic hypocellularity, accompanied by biochemical shifts including elevated transaminases (GOT, GPT), bilirubin, urea, and creatinine, reflecting impaired protein metabolism and excretory function.[63] Autopsy findings from human cases corroborate these effects, revealing visceral congestion predominantly in lungs, heart, and intestines, with gastrointestinal mucosal ulceration and hemorrhage driving initial hypovolemic shock and secondary failure in liver and kidneys via sustained protein synthesis blockade.[66] The temporal progression follows a causal sequence from localized ribosomal damage to systemic decompensation: initial endothelial disruption promotes vascular leakage and fluid shifts (e.g., pulmonary edema from neutrophil-mediated hyperpermeability in inhalation models), escalating to apoptosis-driven necrosis in parenchymal cells and culminating in multi-organ failure within 24-72 hours for low doses, with earlier onset (12-24 hours) at higher exposures due to abrin's superior potency over ricin (10-100-fold lower LD₅₀ in rodents).[67] Unlike ricin, which inflicts broader stromal and endothelial injury in pulmonary tissues, abrin preferentially targets alveolar type II cells with less junctional protein disruption, yet its higher catalytic efficiency accelerates apoptotic thresholds in vascular and epithelial compartments across organs.[67][2]

Toxicokinetics

Abrin, a heterodimeric ribosome-inactivating protein with a molecular weight of approximately 63-65 kDa, demonstrates route-dependent absorption characteristics. Intravenous or intraperitoneal administration in animal models results in rapid systemic uptake, reflecting efficient entry into circulation without significant barriers. In contrast, gastrointestinal absorption is limited due to the toxin's large size, poor intestinal permeability, and partial proteolytic degradation in the gut lumen, though sufficient intact abrin can translocate to cause systemic toxicity in cases of ingestion.[68][69][53] Following absorption, abrin distributes widely throughout tissues, with pharmacokinetic studies in rats and mice indicating highest concentrations in the spleen, followed by the liver and other organs. The galactose-binding B-chain enables receptor-mediated endocytosis, facilitating penetration into cells and contributing to broad tissue dissemination despite the molecule's hydrophilicity overall.[70][53] Abrin undergoes minimal extracellular metabolism, retaining structural integrity to exert its cytotoxic effects intracellularly via A-chain depurination of 28S rRNA. Elimination occurs primarily through renal excretion, with studies in rodents showing detectable radioactivity in urine, largely in non-protein forms suggestive of partial degradation; abrin clears more slowly than the related toxin ricin. Plasma half-life in rat models is estimated on the order of hours, though precise values remain undercharacterized. Bioavailability persists across pH ranges of 2.0-9.0 with no loss of toxicity, while heat treatment at 63°C reduces in vitro cytotoxicity by approximately 30% and delays lethality in mice, with full inactivation above 74°C.[53][30]

Exposure Routes and Clinical Effects

Ingestion Effects

Ingestion of abrin, typically via chewed or crushed seeds of Abrus precatorius, initiates gastrointestinal toxicity with initial symptoms of nausea, vomiting, abdominal pain, and profuse diarrhea, which may become bloody (hematochezia).[66][71] Onset occurs within hours in cases of masticated seeds, contrasting with delayed absorption from whole seeds due to the gastrointestinal barrier, which partially degrades the toxin and reduces bioavailability compared to parenteral routes.[30][32] Progression involves hemorrhagic gastroenteritis, mucosal sloughing, dehydration, and hypovolemic shock, often leading to acute renal failure and multiorgan dysfunction if untreated.[72][73] Autopsy findings in fatal cases confirm extensive gastrointestinal hemorrhage, epithelial necrosis, and submucosal edema.[66] Death typically ensues 1–3 days post-ingestion in severe exposures, with supportive care (e.g., fluids, hemoperfusion) improving survival odds in non-fatal instances.[74][72] Human case reports document lethality from ingestion of a handful (approximately 10–20) of crushed seeds in adults, equating to an estimated oral dose exceeding 10 μg/kg, though the gut barrier renders whole-seed ingestion less potent, with fatalities rarer unless seeds are damaged.[66][75] Pediatric cases, such as an 18-month-old ingesting seeds, manifest similarly but with heightened vulnerability due to lower body mass, presenting with fever, dehydration, and bloody stools.[71] No specific antidote exists; management relies on decontamination and symptom control.[66]

Inhalation Effects

Inhalation of aerosolized abrin primarily targets the respiratory tract, initiating a cascade of inflammatory responses due to the toxin's ribosomal inhibition, which disrupts protein synthesis in alveolar cells. Initial symptoms manifest within 4-8 hours of exposure, including cough, dyspnea, chest tightness, fever, and arthralgia, progressing to severe pulmonary edema and acute respiratory distress syndrome (ARDS).[34][33] Lethality arises from hypoxia secondary to alveolar flooding and systemic toxemia, with death possible within 36-72 hours at high doses, as evidenced by histopathological findings of neutrophil infiltration, oxidative stress, and multi-organ involvement in exposed models.[76][77] Animal studies demonstrate high potency via this route; for instance, in rats exposed head-only to abrin aerosols with particle sizes under 1 µm for 8 minutes, the estimated LC50 is 3.3 µg/kg body weight, indicating orders-of-magnitude greater toxicity compared to oral administration.[34][78] BALB/c mice challenged with 0.2-0.8 LC50 doses of aerosolized abrin exhibited dose-dependent lung inflammation and edema, underscoring the toxin's bioavailability advantage over gastrointestinal exposure, where partial degradation by digestive enzymes reduces efficacy.[76] This bypass of enteric barriers enhances systemic absorption directly from pulmonary vasculature, amplifying end-organ damage beyond the lungs.[3] Biosecurity assessments highlight aerosol dissemination risks, particularly in confined environments, where low-dose exposures could yield mass casualties due to abrin's stability and ease of weaponization, as inferred from rat models surviving only up to 5 LCt50 equivalents post-immunization challenges.[79][80] Unlike ingestion, which often localizes initial effects to the gut, inhalation induces rapid hematogenous spread, potentiating remote toxicities while prioritizing respiratory failure as the proximate cause of death.[3]

Dermal and Injection Effects

Abrin exhibits limited dermal absorption through intact skin, posing a low risk of systemic toxicity under normal conditions, though penetration can occur via abraded, irritated, or wounded skin, potentially leading to localized effects such as redness, pain, irritation, and blistering.[2] In such cases, effects may manifest within 24 hours, including allergic-like reactions with edema and possible hemorrhagic oozing if exposure involves open wounds.[81] Systemic uptake remains minimal compared to other routes unless large quantities contact damaged tissue, as abrin's protein nature hinders passive diffusion across epidermal barriers.[1] Parenteral administration, such as via intramuscular or subcutaneous injection, circumvents skin barriers, enabling rapid systemic dissemination and heightened potency, with estimated human lethal doses of 0.1–1 µg/kg body weight.[82] Local effects at the injection site include immediate vascular damage, necrosis, painful swelling, ecchymosis, and hemorrhagic fluid exudation, often progressing to tissue breakdown.[83] A documented fatal case involved intramuscular injection of abrin-contaminated material, resulting in delayed symptom onset followed by multiorgan failure, including hepatic and renal dysfunction, despite supportive care.[84][82] Unlike dermal exposure, injection yields toxicity comparable to or exceeding intravenous routes in animal models, with death attributable to ribosome inactivation halting protein synthesis across vital organs.[85] Hypersensitivity reactions, though rare, may exacerbate local necrosis and contribute to accelerated systemic decline in sensitized individuals.[81]

Potential Applications

Medical Research and Therapeutics

Abrin, a type II ribosome-inactivating protein (RIP) derived from Abrus precatorius seeds, has been investigated since the 1970s for its cytotoxic potential against cancer cells due to the A-chain's enzymatic inhibition of protein synthesis.[86] Early in vitro studies demonstrated abrin's higher toxicity toward tumor cells compared to normal cells, with selective killing observed in cell lines such as those from human carcinomas.[54] This differential cytotoxicity arises from abrin's ability to exploit overexpressed receptors on malignant cells for uptake, though mechanisms remain incompletely elucidated and limited to preclinical models.[86] Subsequent research has explored abrin isoforms, such as abrin P2, which suppress proliferation and induce apoptosis in colon cancer cells via caspase activation and cell cycle arrest in vitro and in xenograft models.[87] Abrin's potency exceeds that of the related toxin ricin, with animal lethality data indicating abrin's LD50 is several-fold lower (e.g., 0.91 μg/kg in mice versus ricin's higher threshold), suggesting enhanced therapeutic efficacy if targetable.[63][88] However, this advantage is offset by a narrow therapeutic index, where off-target effects cause systemic toxicity, including multi-organ failure, limiting safe dosing.[65] Immunogenicity poses a further barrier, as abrin's plant-derived structure elicits strong antibody responses, potentially neutralizing repeated administrations and complicating chronic therapy.[89] While reviews highlight abrin's broad anticarcinogenic activity across cell lines (e.g., via prohibitin upregulation in apoptosis pathways), no human clinical trials have advanced beyond conceptual stages, underscoring unproven efficacy against real-world tumor heterogeneity and causal risks of unintended cytotoxicity.[90][91] Empirical data thus portray abrin as a potent but constrained candidate, with toxicity profiles precluding standalone use absent advanced delivery innovations.[41]

Immunotoxin Development

The A-chain of abrin, a ribosome-inactivating protein (RIP) that depurinates a specific adenine residue in the 28S rRNA of the 60S ribosomal subunit, has been conjugated to monoclonal antibodies to form immunotoxins aimed at selectively delivering cytotoxicity to cancer cells expressing targeted surface antigens.[89] These constructs exploit the enzymatic potency of abrin A-chain, which is approximately 10- to 100-fold more toxic than ricin A-chain on a molar basis in cell-free systems, to inhibit protein synthesis following receptor-mediated endocytosis and retrograde trafficking to the endoplasmic reticulum.[92] Early immunotoxin designs linked the intact abrin A-chain to antibodies via chemical cross-linkers such as N-succinimidyl 3-(2-pyridyldithio)propionate (SPDP), enabling targeted killing of antigen-positive cells while minimizing off-target effects from the B-chain's nonspecific binding.[93] In preclinical models, abrin A-chain immunotoxins demonstrated efficacy against solid tumors and hematologic malignancies. For instance, an abrin A-chain conjugate with the monoclonal antibody SWA11, which targets a small cell lung cancer-associated antigen, exhibited potent in vitro cytotoxicity against antigen-expressing cell lines with IC50 values in the picomolar range and showed tumor regression in xenograft models when administered systemically, though nonspecific hepatotoxicity limited dosing.[92] Similarly, conjugates targeting carcinoma cells via monoclonal antibodies delivered abrin A-chain intracellularly, resulting in >90% inhibition of protein synthesis in target cells but requiring optimization to reduce bystander killing via free A-chain release.[94] In leukemia models, while ricin-based immunotoxins predominate clinical exploration, abrin A-chain hybrids have shown amplified cytotoxicity when engineered for low-dose delivery, leveraging paradoxical increases in protein synthesis at sublethal concentrations (1-10 ng/mL) to enhance T-cell superantigen responses in coculture systems, potentially broadening antitumor immunity.[95] Recent engineering advances include recombinant fusions of abrin A-chain with targeting moieties like Shiga toxin B-subunit (stxB) for multivalent binding to globotriaosylceramide on cancer cells, improving endosomal escape and potency in prostate and colon carcinoma lines without full antibody scaffolds to evade immunogenicity.[96] Monoclonal antibodies such as 10D8, while primarily neutralizing free abrin, inform conjugate design by mapping epitopes that preserve A-chain activity post-linkage.[97] However, clinical translation remains challenged by vascular leak syndrome, rapid clearance due to anti-abrin antibodies in humans, and off-target ribosomal inactivation in normal cells, with no abrin-based immunotoxins advancing beyond phase I trials as of 2024, unlike Pseudomonas exotoxin derivatives.[98] These hurdles necessitate deglycosylation, truncation, or nanoparticle encapsulation to enhance specificity and half-life.[99]

Risks and Security Concerns

Accidental and Intentional Incidents

Accidental exposures to abrin primarily occur through ingestion of seeds from Abrus precatorius, often incorporated into jewelry such as necklaces and bracelets, where children may chew or swallow them after accessing the beads. In the United States, recalls of thousands of such jequirity bean-based products in 2012 highlighted risks to young children mistaking the attractive red-and-black seeds for candy, leading to potential fatal poisoning due to the toxin's inhibition of protein synthesis.[100] Documented pediatric cases include fatalities from even small quantities, with symptoms manifesting as severe gastrointestinal distress followed by multiorgan failure, underscoring the toxin's estimated lethal dose of 0.1-1 microgram per kilogram body weight.[101] In regions like Asia, where A. precatorius seeds are used in traditional practices including adornments and purported medicines, accidental poisonings are more prevalent, often linked to cultural normalization despite the seeds' intact coats providing minimal natural protection against toxicity when breached. Case reports from India and surrounding areas describe unintentional ingestions resulting in vomiting, diarrhea, and hepatic/renal damage, with underreporting attributed to misdiagnosis as generic gastroenteritis or ricin-like toxidromes.[83] Empirical data indicate these incidents exceed those in Western contexts, where availability is lower, though global forensic analyses confirm accidental cases outnumber intentional ones due to the plant's ornamental and ritualistic roles outweighing any negligible benefits in unverified traditional uses.[4] Intentional incidents remain rare but include suicides via seed ingestion or injection, exploiting abrin's rapid cellular toxicity. A 2010 case involved a deliberate overdose ordered online, presenting with abdominal pain and coagulopathy, though survival occurred with aggressive supportive care.[64] More recent examples encompass a 2022 suicide attempt by a 43-year-old woman consuming 25 crushed seeds, leading to fatal multiorgan failure despite intervention, and a 2024 autopsy-confirmed case of a 37-year-old female's lethal ingestion of pulverized seeds.[75][102] Homicidal uses are exceptionally uncommon, with forensic literature noting only sporadic attempts, often foiled by the toxin's detectability via biomarkers like l-abrine, emphasizing that while culturally embedded risks amplify accidental exposures, intentional acts reflect isolated desperation rather than widespread patterns.[103]

Bioterrorism Potential

Abrin is classified as a Category B bioterrorism agent by the Centers for Disease Control and Prevention (CDC), indicating moderate ease of dissemination and potential for moderate morbidity and mortality in a population.[46] This categorization stems from its high toxicity, relative stability in environmental conditions, and straightforward extraction from the seeds of Abrus precatorius, which are commercially available and require minimal processing to yield crude toxin preparations.[104] Unlike Category A agents, abrin has not been documented in large-scale attacks, but its parallels to ricin—another plant-derived toxin involved in multiple thwarted plots—underscore its appeal for small-scale terrorist operations.[35] Weaponization feasibility relies on abrin's capacity for aerosolization, as the toxin demonstrates stability lasting days to months under varying environmental factors when prepared as powders or liquids, facilitating inhalation delivery akin to ricin. Extraction involves simple mechanical disruption of seeds followed by basic purification steps, enabling non-state actors to produce lethal quantities—estimated at microgram levels per victim—with household equipment, though yields are often diminished by impurities in unrefined extracts that can degrade efficacy or introduce contaminants.[3] Its potency, exceeding ricin's by 10- to 100-fold in some models, positions abrin as viable for targeted assassinations or localized releases causing high casualties among exposed individuals, with an estimated human lethal dose via inhalation as low as 3.3 micrograms per kilogram.[65][35] Empirical assessments highlight accessibility as a primary enabler, countering narratives that minimize risks due to technical hurdles; seeds' global availability and toxin's resistance to heat and pH changes up to certain thresholds support covert production without specialized facilities.[62] However, barriers include inconsistent aerosol dispersibility in impure forms, which can lead to clumping or reduced inhalability, and the absence of validated mass-production protocols, limiting scalability beyond small groups.[105] Recent analyses affirm abrin's threat profile for asymmetric threats, emphasizing the need for vigilance given documented interest in similar toxins despite no confirmed deployments.[46]

Detection and Countermeasures

Analytical Detection Methods

Abrin detection employs immunoassays and mass spectrometry techniques that specifically target its A-chain (ribosome-inactivating protein) and B-chain (lectin) for high specificity, distinguishing it from structurally similar toxins like ricin.[48] Enzyme-linked immunosorbent assays (ELISAs) using monoclonal antibodies against abrin isoforms provide quantification in biological and environmental samples, achieving limits of detection (LODs) of 0.5–10 ng/mL in food matrices.[106] Commercial ELISA kits, such as monoclonal capture formats, confirm abrin presence in stool or plasma with recoveries around 660 ng/g in buffered samples.[7] Immuno-MALDI-TOF mass spectrometry integrates antibody enrichment with rapid peptide analysis (<5 minutes), enabling isoform-specific detection in complex food matrices without chromatographic separation; LODs reach 8–200 ng for depurination-active forms.[107] A 2024 affinity enrichment workflow using MALDI-TOF differentiates enzymatically active abrin from degraded or non-toxic variants via single-sample processing, addressing forensic needs for active toxin confirmation.[48] Cross-reactivity with ricin poses challenges in assays due to shared galactose-binding motifs, though abrin-specific monoclonal antibodies minimize this (e.g., <8% at 10 μg/mL abrin).[45] Field-deployable biosensors, including lateral flow assays and self-driven microfluidic chips, offer rapid screening (10–15 minutes) with LODs of 3–10 ng/mL, suitable for biosecurity but requiring validation against matrix interferences.[108] Emerging 2025 activity-based methods, like FSA-LFA targeting AP lyase function, enhance differentiation from ricin by confirming enzymatic activity at optimal pH 4.4 and 63°C.[109]

Biosecurity and Prevention Strategies

In the United States, abrin is classified as a HHS select toxin under the Federal Select Agent Program, mandating registration for any entity possessing, using, or transferring quantities exceeding 1000 mg or equivalent seed amounts capable of yielding that threshold, with strict security, inventory, and transfer protocols to mitigate misuse risks.[110][111] These regulations, enforced by the CDC and USDA, require validated training, biosecurity plans, and incident reporting to prevent unauthorized access, drawing on empirical evidence that controlled possession reduces diversion incidents compared to unregulated environments.[112] Internationally, abrin falls under the Biological and Toxin Weapons Convention, prohibiting development or stockpiling for offensive purposes, though enforcement varies by nation.[113] Prevention of accidental exposure emphasizes public education on the hazards of Abrus precatorius seeds, commonly used in rosary beads or jewelry, where intact seeds pose low risk but damage from chewing or breakage releases abrin, leading to documented poisonings.[1] Health authorities recommend avoiding ingestion or handling without precautions, with U.S. Customs and Border Protection screening biological imports, including seeds, to curb unregulated entry that could facilitate toxin extraction.[114] Empirical data from poisoning cases underscore the efficacy of awareness campaigns, as most incidents involve cultural or ornamental uses rather than deliberate acts.[2] Laboratory biosecurity protocols for abrin handling incorporate risk-based containment, typically at Biosafety Level 2 with enhancements like chemical fume hoods or biosafety cabinets, double-gloved operations, and respiratory protection to address aerosol or injection hazards.[115] Principal investigators must develop toxin-specific safety plans, including spill decontamination via bleach or autoclaving and waste inactivation, supported by studies showing that procedural adherence prevents occupational exposures.[116] Recent biennial reviews of select agents, including 2024 updates, have reinforced these measures without altering abrin's status, prioritizing empirical validation of safeguards amid advancing research on toxin stability.[117] Deterrence relies on layered controls—registration, monitoring, and rapid response capabilities—causally linking regulatory stringency to lowered proliferation risks, as unregulated access historically correlates with higher incident rates.[118]

Treatment Approaches

Supportive Medical Management

Supportive medical management for abrin poisoning emphasizes decontamination and symptom palliation, as no specific antidote exists. Initial steps involve promptly removing the patient from the exposure source and decontaminating affected areas: for dermal contact, thorough washing with soap and water; for ocular exposure, irrigation with saline or water; and for inhalation, relocation to fresh air with respiratory support as needed. Gastrointestinal decontamination, if ingestion occurred within hours, may include administration of activated charcoal to adsorb unbound toxin, though its efficacy diminishes with delayed presentation.[2][4][6] Hospital-based care centers on maintaining vital functions through intravenous fluid resuscitation to address hypovolemia and hypotension, electrolyte correction, and antiemetic therapy to control vomiting and dehydration. Patients require close monitoring for multi-organ failure, including hepatic and renal function, with mechanical ventilation instituted for respiratory distress or apnea, particularly in inhalation cases where pulmonary edema can develop. Hemodynamic support, such as vasopressors, may be necessary for refractory shock, which often manifests 24-72 hours post-exposure.[1][8][2] Empirical data from rare documented cases indicate that early intervention improves outcomes, with survival reported in intentional ingestions treated aggressively with fluids and supportive measures, though lethality exceeds 90% for doses above 0.2 mg/kg without prompt care. Limitations of this approach include its inability to neutralize intracellular toxin effects, underscoring gaps in therapeutic readiness for severe exposures where delayed onset complicates prognosis.[8][4]

Experimental Neutralization Therapies

Research into experimental neutralization therapies for abrin poisoning has primarily focused on antibody-based countermeasures, as no approved antidotes exist. Polyclonal and monoclonal antibodies targeting the toxin's A chain have demonstrated preclinical efficacy in blocking enzymatic activity and mitigating cytotoxicity. For instance, the humanized monoclonal antibody S008, developed in 2022, exhibits high affinity for abrin's A subunit and neutralizes toxicity both in vitro—by inhibiting protein synthesis inhibition in cell lines—and in vivo, providing post-exposure protection in mouse models when administered within hours of intoxication.[23] Similarly, monoclonal antibody D6F10 interferes with abrin's cellular attachment and internalization, rescuing cells and mice from lethal doses in preclinical studies.[38] Another antibody, mAb 10D8, neutralizes abrin-a and crude extracts, highlighting potential for broad-spectrum activity against abrin isoforms.[119] Small-molecule inhibitors remain in nascent stages, with limited abrin-specific data. Compounds like E-N-(2-acetyl-phenyl)-3-phenyl-acrylamide have shown inhibitory effects on abrin's catalytic site in enzymatic assays, akin to their action against related ribosome-inactivating proteins such as ricin, but in vivo efficacy and selectivity require further validation.[120] As of 2025, preclinical models underscore timing as a critical factor, with antibodies most effective when delivered within 24 hours post-exposure to prevent irreversible cellular damage; delays beyond this window reduce survival rates significantly in pulmonary and systemic intoxication simulations.[35] These therapies offer cautious promise over sole reliance on supportive care, yet human clinical trials are absent, and challenges including isoform variability and delivery optimization persist.[35]

References

  1. Abrin | Chemical Emergencies - CDC
  2. Abrin: Biotoxin | NIOSH - CDC
  3. Abrin - an overview | ScienceDirect Topics
  4. A Case of Abrin Toxin Poisoning, Confirmed via Quantitation of l ...
  5. Abrin poisoning - PubMed
  6. [PDF] Facts About Abrin - CDC Stacks
  7. Differentiation, Quantification and Identification of Abrin and Abrus ...
  8. Survival after an Intentional Ingestion of Crushed Abrus Seeds - NIH
  9. Abrus precatorius L. - USDA Plants Database Classification ID Report
  10. Abrus precatorius L. - USDA Plants Database Plant Profile General
  11. Abrus precatorius - North Carolina Extension Gardener Plant Toolbox
  12. Abrus precatorius / [Species detail] / Plant Atlas
  13. Studies on the active principle from Abrus precatorius L ...
  14. Research advances and prospects of legume lectins - PMC - NIH
  15. Are Vicilins Another Major Class of Legume Lectins? - PMC
  16. One step Purification and Characterisation of Abrin Toxin from Abrus ...
  17. Abrus precatorius L. | Plants of the World Online | Kew Science
  18. Abrus precatorius L. - World Flora Online
  19. Abrus precatorius - an overview | ScienceDirect Topics
  20. Abrus precatorius (Rosary Pea) - FSUS
  21. Abrus precatorius subsp. africanus - Lucid key
  22. [PDF] effect of temperatures and salinity on seed germination rate of rosary ...
  23. A Novel Humanized Anti-Abrin A Chain Antibody Inhibits Abrin ...
  24. Gaps in forensic toxicological analysis: The veiled abrin
  25. 1ABR: CRYSTAL STRUCTURE OF ABRIN-A - RCSB PDB
  26. Abrin-a - Abrus precatorius (Indian licorice) | UniProtKB | UniProt
  27. Abrin - an overview | ScienceDirect Topics
  28. N-Glycosylation Profile of Abrin Certified EU Reference Material
  29. (PDF) Purification and Characterization of Two Major Toxic Proteins ...
  30. Abrin Toxicity and Bioavailability after Temperature and pH Treatment
  31. Abrin toxicity and bioavailability after temperature and pH treatment
  32. Influence of Food Matrices on the Stability and Bioavailability of Abrin
  33. Abrin - an overview | ScienceDirect Topics
  34. [PDF] NRT Quick Reference Guide: Biotoxins: Ricin, Abrin
  35. Ricin and Abrin in Biosecurity: Detection Technologies and Strategic ...
  36. On the Toxic Proteins Abrin and Ricin - Journal of Biological Chemistry
  37. (PDF) Kinetics of binding of the toxic lectins abrin and ricin to surface ...
  38. A Neutralizing Antibody to the A Chain of Abrin Inhibits Abrin Toxicity ...
  39. Differential toxicity of abrin in human cell lines of different organ origin
  40. Small-Molecule Inhibitor Leads of Ribosome-Inactivating Proteins ...
  41. A Novel Humanized Anti-Abrin A Chain Antibody Inhibits ... - Frontiers
  42. Sensitive Detection and Differentiation of Biologically Active Ricin ...
  43. Inhibition of protein synthesis leading to unfolded protein response ...
  44. Ribosome-inactivating proteins: Potent poisons and molecular tools
  45. Establishment and Comparison of Detection Methods for Ricin and ...
  46. Ricin and Abrin as Possible Agents of Bioterror - ResearchGate
  47. N-Glycosylation Profile of Abrin Certified EU Reference Material - PMC
  48. Mass Spectrometric Detection and Differentiation of Enzymatically ...
  49. Epidemiology of Pathogens Listed as Potential Bioterrorism Agents ...
  50. Drugs as Chemical Weapons: Past and Perspectives - MDPI
  51. The history of ricin, abrin and related toxins - PubMed
  52. The history of ricin, abrin and related toxins - ScienceDirect
  53. Toxicity, distribution and elimination of the cancerostatic lectins abrin ...
  54. Ribosome-Inactivating Proteins from Plants: A Historical Overview
  55. Structure-Function Analysis and Insights into the Reduced Toxicity of ...
  56. Isolation and properties of abrin: a toxic protein inhibiting ... - PubMed
  57. Abrus precatorius - Useful Tropical Plants
  58. The traditional uses, phytochemistry and pharmacology of Abrus ...
  59. Detoxification of Abrus precatorius L. seeds by Ayurvedic Shodhana ...
  60. Are rosary peas poisonous?
  61. Quantification of Ricinine and Abrine in Human Plasma by HPLC ...
  62. Abrin Toxicity and Bioavailability after Temperature and pH Treatment
  63. [PDF] Purification and dose-dependent toxicity study of abrin in swiss ...
  64. Attempted Suicide, by Mail Order: Abrus precatorius
  65. Dose dependent acute toxicity of abrin in Balb/c mice after ...
  66. Abrus precatorius Poisoning: A Retrospective Study of 112 Patients
  67. Characterization of Lung Injury following Abrin Pulmonary ...
  68. Abrin - an overview | ScienceDirect Topics
  69. Abrus precatorius L. (PIM 001) - INCHEM
  70. Fas/Fas Ligand Apoptotic Pathway Is Involved in Abrin-Induced ...
  71. Abrin Poisoning in an 18-Month-Old Child - PMC - NIH
  72. Acute abrin poisoning treated with continuous renal... - LWW
  73. A Case of Poisoning with Abrus precatarius Complicated with ...
  74. A fatal poisoning due to consumption of crushed Abrus precatorius ...
  75. Fatal Curiosity: A Case of Suicidal Attempt by Abrus Seeds ...
  76. Neutrophil mediated inflammatory lung damage following single ...
  77. Toxicity of Abrin by Inhalation in the Rat - ResearchGate
  78. Inhalation Toxicology and Histopathology of Ricin and Abrin Toxins
  79. Protection against inhalation toxicity of ricin and abrin by immunisation
  80. [PDF] The Toxicology of Ricin and Abrin Toxins - Studies on Immunisation ...
  81. When nature turns deadly: A look at Abrin - EMBL-EBI
  82. Fatal abrin poisoning by injection - PubMed
  83. Trends in the analysis of abrin poisoning for forensic purposes
  84. Fatal Multiorgan Failure from Intramuscular Injection of Abrin Seed
  85. Acute disseminated encephalomyelitis due to abrus precatorius ...
  86. Abrin and Ricin: New Anti-tumour Substances - Nature
  87. Abrin P2 suppresses proliferation and induces apoptosis of colon ...
  88. Prophylactic efficacy of some chemoprotectants against abrin ...
  89. Abrin Immunotoxin: Targeted Cytotoxicity and Intracellular ...
  90. comprehensive review on anticarcinogenic effect of abrin
  91. Involvement of Prohibitin Upregulation in Abrin-Triggered Apoptosis
  92. Molecular and biological properties of an abrin A chain immunotoxin ...
  93. Abrin Immunotoxin: Targeted Cytotoxicity and Intracellular ... - PubMed
  94. Delivery of Ricin and Abrin A-Chains to Human Carcinoma Cells in ...
  95. Abrin Toxin Paradoxically Increases Protein Synthesis in Stimulated ...
  96. Targeted delivery of the abrin-a a-chain to cancer cells
  97. Neutralizing Monoclonal Antibody, mAb 10D8, Is an Effective ... - MDPI
  98. Critical Issues in the Development of Immunotoxins for Anticancer ...
  99. Abrin Immunotoxin: Targeted Cytotoxicity and Intracellular ... - NIH
  100. Thousands of deadly bracelets made from toxic plant recalled
  101. (PDF) An Arrow Poison (Abrus Precatorius) Causing Fatal Poisoning ...
  102. A fatal poisoning due to consumption of crushed Abrus precatorius ...
  103. Differentiation, Quantification and Identification of Abrin and Abrus ...
  104. Comprehensive Review of Bioterrorism - StatPearls - NCBI Bookshelf
  105. Of Beans and Beads: Ricin and Abrin in Bioterrorism and Biocrime
  106. Detection of Abrin in Food Using Enzyme-Linked Immunosorbent ...
  107. Development and Evaluation of an Immuno-MALDI-TOF Mass ...
  108. Rapid detection of abrin in foods with an up-converting phosphor ...
  109. Enhanced detection of abrin: Unraveling AP lyase activity and ...
  110. Select Agents and Toxins List
  111. Permissible Toxin Amounts - Federal Select Agent Program
  112. 42 CFR Part 73 -- Select Agents and Toxins - eCFR
  113. A Glycoprotein-Based Surface-Enhanced Raman Spectroscopy ...
  114. Importing Biological Materials into the United States
  115. Guidelines for Work With Toxins of Biological Origin - Cornell EHS
  116. [PDF] Biological Toxin Safe Work Practices
  117. Possession, Use, and Transfer of Select Agents and Toxins; Biennial ...
  118. Appendix A. Summary of Select Toxin Natural Environments ...
  119. Neutralizing Monoclonal Antibody, mAb 10D8, Is an Effective ...
  120. 3-phenyl-acrylamide targets abrin and ricin toxicity: Hitting two toxins ...
User Avatar
No comments yet.